Stripe and Advent's $53B Bid for PayPal Deemed Inadequate by Board
The board has not yet formally responded to the proposal.
Already have an account? Sign in.
The board has not yet formally responded to the proposal.
Tempest gets an exclusive option to license Senlang’s CD7-targeted lentiviral in-vivo CAR-T, now in Phase 1 for relapsed multiple myeloma.
Axon plans $1 billion of 0% convertible notes due 2031, plus a $150 million option.
Senators failed to reach 60 votes on the Clarity Act. All Democrats and four Republicans stopped debate on digital asset rules.